|
Compound class:
Synthetic organic
Comment: This compound is an orally bioavailable inhibitor of the deubiquitinating enzyme ubiquitin specific peptidase 1 (USP1) [1]. It is proposed for anti-tumour activity. Amongst its physiological and tumourigenic actions, USP1 is an important survival factor for homologous recombination deficiency (HRD) mutant tumours, which indicates potential as a synthetic lethal target in these tumours.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Yang T, Cui X, Li Q, Teng Y, Tang M, Zou X, Cen X, Chen L, Zhao M, Yang L et al.. (2026)
Optimization of a Series of Novel 1H-Pyrrolo[3,2-c]pyridine-Based USP1 Inhibitors with Potent In Vivo Antitumor Activity. J Med Chem, Online ahead of print. DOI: 10.1021/acs.jmedchem.6c01009 |